4//SEC Filing
Kramer Kelly A. 4
Accession 0001629885-25-000005
CIK 0000882095other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:54 PM ET
Size
13.2 KB
Accession
0001629885-25-000005
Insider Transaction Report
Form 4
Kramer Kelly A.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-26$81.00/sh+2,806$227,286→ 4,145 total - Sale
Common Stock
2025-11-26$127.11/sh−2,806$356,671→ 1,339 total - Exercise/Conversion
Common Stock
2025-11-28$81.00/sh+2,805$227,205→ 4,144 total - Sale
Common Stock
2025-11-28$127.10/sh−2,805$356,516→ 1,339 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-11-26−2,806→ 2,805 totalExercise: $81.00Exp: 2026-08-19→ Common Stock (2,806 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-11-28−2,805→ 0 totalExercise: $81.00Exp: 2026-08-19→ Common Stock (2,805 underlying)
Footnotes (2)
- [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.
- [F2]Options vest quarterly over the first year of service and were fully vested on August 19, 2017.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001629885
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:54 PM ET
- Size
- 13.2 KB